Haijun Wang
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Pituitary Gland Disorders and Treatments 25
- Growth Hormone and Insulin-like Growth Factors 9
- Surgery 13
- Adrenal and Paraganglionic Tumors 10
- Head and Neck Surgical Oncology 3
- Co-authors
- Yonghong Zhu (14 shared papers)Dongsheng He (10 shared papers)Zhigang Mao (5 shared papers)Bin Hu (4 shared papers)Zongming Wang (9 shared papers)Youfan Ye (3 shared papers)Hongyang Zhao (1 shared paper)Wenli Chen (5 shared papers)
- Journals
- Frontiers in Endocrinology (3 papers)Pituitary (2 papers)Journal of Neuro-Oncology (2 papers)Journal of Organometallic Chemistry (1 paper)Therapeutics and Clinical Risk Management (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Haijun Wang
31 papers receiving 348 citations
Peers
Comparison fields: 5 of 77
- Endocrinology, Diabetes and Metabolism 246
- Genetics 102
- Epidemiology 84
- Surgery 82
- Radiology, Nuclear Medicine and Imaging 36
Countries citing papers authored by Haijun Wang
This map shows the geographic impact of Haijun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijun Wang more than expected).
Fields of papers citing papers by Haijun Wang
This network shows the impact of papers produced by Haijun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijun Wang. The network helps show where Haijun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Haijun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 38 | |
| 2 | 2011 | 28 | |
| 3 | 2015 | 25 | |
| 4 | 2021 | 25 | |
| 5 | 2013 | 24 | |
| 6 | 2021 | 20 | |
| 7 | 2017 | 20 | |
| 8 | 2022 | 18 | |
| 9 | 2021 | 18 | |
| 10 | 2011 | 18 | |
| 11 | 2010 | 15 | |
| 12 | 2018 | 13 | |
| 13 | Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits. | 2014 | 13 |
| 14 | 2023 | 9 | |
| 15 | 2022 | 9 | |
| 16 | 2014 | 7 | |
| 17 | 2017 | 7 | |
| 18 | 2019 | 7 | |
| 19 | 2018 | 6 | |
| 20 | 2023 | 5 |
About Haijun Wang
Haijun Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 353 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (25 papers), Adrenal and Paraganglionic Tumors (10 papers), Growth Hormone and Insulin-like Growth Factors (9 papers), Glioma Diagnosis and Treatment (8 papers), Meningioma and schwannoma management (6 papers), Head and Neck Surgical Oncology (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Ophthalmology and Eye Disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (246 citations), Genetics (102 citations), Epidemiology (84 citations), Surgery (82 citations) and Radiology, Nuclear Medicine and Imaging (36 citations). Haijun Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yonghong Zhu, Dongsheng He, Zhigang Mao, Bin Hu, Zongming Wang, Youfan Ye, Hongyang Zhao, Wenli Chen, Xintong Zhao and Zhigang Mao. Their work appears in journals such as Frontiers in Endocrinology, Pituitary, Journal of Neuro-Oncology, Journal of Organometallic Chemistry and Therapeutics and Clinical Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.